Oviedo Medical Research

Oviedo Medical Research is a private, service-based clinical research company founded in 2010, serving as a site management organization for later-stage (Phase II-IV) clinical trials. It leverages its state-of-the-art facility in Central Florida to enroll patients for studies sponsored by large pharmaceutical and biotech partners, with a current pipeline emphasizing GLP-1 therapies for weight loss and diabetes, as well as diagnostic devices. The company's business model is built on providing clinical trial services, generating revenue through research contracts, and it occupies a niche in the growing clinical research outsourcing market.

Integrated clinical trial site with capabilities for pharmaceutical and device studies, including patient recruitment, screening, enrollment, and trial management infrastructure.

Competes with other standalone clinical research sites, large national and global CROs, and hospital-affiliated research institutes. Differentiation is based on enrollment speed, data quality, and therapeutic area expertise in metabolic disorders within the Central Florida region.